COL4A1 Mutations Cause Neuromuscular Disease With Tissue-Specific Mechanistic Heterogeneity

American Journal of Human Genetics- United States

doi 10.1016/j.ajhg.2019.03.007

Full Text

Abstract

Available in

Categories

Date

May 1, 2019

Authors

Cassandre Labelle-Dumais

Douglas B. Gould

Publisher

Elsevier BV

Related search

COL4A1 Mutations as a Monogenic Cause of Cerebral Small Vessel Disease: A Systematic Review

Cardiovascular Medicine

Specialized Nursing

English

Genetic Heterogeneity in Rubinstein-Taybi Syndrome: Mutations in Both the CBP and EP300 Genes Cause Disease

American Journal of Human Genetics

English

Mutations in Bcl9 and Pygo Genes Cause Congenital Heart Defects by Tissue-Specific Perturbation of WNT/Β-Catenin Signaling

Genes and Development

Developmental Biology

English

Dynamin 2 (DNM2) as Cause Of, and Modifier For, Human Neuromuscular Disease

Neurotherapeutics

English

Mutations in KARS Cause a Severe Neurological and Neurosensory Disease With Optic Neuropathy

English

NPMc+ Cooperates With Flt3/Itd Mutations to Cause Acute Leukemia Recapitulating Human Disease

Experimental Hematology

Cancer Research

Molecular Biology

English

Mutations in SEC63 Cause Autosomal Dominant Polycystic Liver Disease

Nature Genetics

English

Disease-Associated GPR56 Mutations Cause Bilateral Frontoparietal Polymicrogyria via Multiple Mechanisms

Journal of Biological Chemistry

Molecular Biology

English

Tissue-Specific Mutations in BRAF and EGFR Necessitate Unique Therapeutic Approaches

Trends in Cancer

Cancer Research

English